Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes drug class may change how the bladder behaves

NCT ID NCT07716774

Ongoing Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study looks at how SGLT-2 inhibitors, a common class of diabetes drugs, affect lower urinary tract symptoms such as frequent urination, urgency, and nighttime trips to the bathroom. Researchers will follow adults with type 2 diabetes who are starting an SGLT-2 inhibitor for the first time, tracking their bladder symptoms using a diary and a questionnaire before and after one month of treatment. The goal is to better understand any changes in bladder function that may occur with this medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SGLT-2 inhibitor (a class of diabetes drugs that lower blood sugar by causing the kidneys to excrete glucose in urine)
What this could lead to
If this study finds a link, it could help doctors better understand how SGLT-2 inhibitors affect bladder function and guide treatment choices for people with diabetes.
What could go wrong
This is a small, observational study without a control group, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACK SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOWER URINARY TRACK SYMPTOMS OVERACTIVE BLADDER SGLT2 INHIBITORS

Contacts and locations

Locations

  • Marmara University School of Medicine Urology Department

    Istanbul, Pendik, 34854, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.